Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells

Go back to Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells
(NASDAQ: AUTL) Delayed: 1.51 --0 (-0%)
Previous Close $1.51    52 Week High
Open $1.52    52 Week Low
Day High $1.57    P/E N/A 
Day Low $1.50    EPS
Volume 464,646